-
Study aim
-
Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primary parous women with preeclampsia
-
Design
-
This study is a randomized clinical trial with two parallel control and intervention groups. Participants (88 eligible women with inclusion criteria) will be entered the study through convenient sampling. Allocation will be done using block randomization.
-
Settings and conduct
-
Pre-natal and Emergency wards of Kamali hospital in Karaj
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria:1-primiparous women with 26-34 weeks gestational age
2-singleton pregnancy 3-non-severe preeclampsia 4-low risk results in the first and second trimesters fetal screenings 5-persian race and at least having reading and writing literacy. Exclusion criteria:1-physical and mental illnesses (such as cardio-respiratory disease, diabetes mellitus and gestational diabetes, seizure, depression, anxiety disorders ,etc) 2- history of infertility and/or repeated miscarriage 3- vaginal hemorrhage and/or leaking amniotic fluid and/or uterine contractions 4- recent severe stress and/or anxiety 5- intrauterine growth restriction 6- usage of alcohol and/or cigarettes and/or drugs
-
Intervention groups
-
In the intervention group, in addition to routine prenatal care, progressive muscle relaxation will be performed and the control group will receive only routine prenatal care
-
Main outcome variables
-
blood pressure, proteinuria, fasting blood sugar, maternal weight gain, ammonium fluid index, gestational age at delivery, becoming severe preeclampsia, fetal movements, and fetal heart rate, l APGAR score, and neonatal anthropometric indices